• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Issues that matter
    • COVID-19 in India
    • Inadequate safe drinking water
    • Poor sanitation
    • Environmental health
    • Infectious disease
      • Hepatitis C
    • Noncommunicable Diseases (NCDs)
    • Malnutrition
    • High infant mortality
    • Mental health
    • Sex and gender discrimination
  • Special Focus
    • Interviews
      • Exclusive Interviews
      • Readers Interviews
    • Vaccine Hesitancy
  • News
  • PandemiCast
  • Partner’s Press Office

Health Issues India

Health issues in India

  • Home
  • About Us
  • Editorial Team
  • Subscribe
  • Contribute
  • Sponsor
  • Contact Us
You are here: Home / Featured / Some important cancer drugs are still not available in India…

Some important cancer drugs are still not available in India…

December 7, 2013 By Shikha Nayyar Leave a Comment

Share

Lately there have been many pharmaceutical industry debates, articles about licensing and the Indian pharma industries in the news. Here is another article in Business Today and it provides a perspective from an oncologist Dr. Radheshyam Naik, who works at HealthCare Global (HCG), a Bangalore­based hospital chain that specialises in caring for patients with cancer, and sees about 150 cancer patients a month. While the pharma debate continues and we do not support any one side of the argument, it is important to ask what will happen to people who may need an essential drug on an urgent basis?

Cancer drugs not sold in IndiaAbout one­ tenth of Dr. Naik’s patients have ailments for which drugs exist but are not available in India. Among them is a 45­ year­old software professional who has a kind of bone marrow cancer. The patient, who does not want to be identified, may at best be able to pull along for another six to nine months on drugs currently available. He is being treated with thalidomide but he needs pomalidomide which is not available in India. This new drug is life­extending, rather than life­saving, but even that can make a big difference as it would make things better for him for at least the next two years, by which time there may be another drug available that could either extend his life further or offer a new solution.There are more than a dozen drugs in important cancer treatment areas that are not available in India and this is a matter of concern for oncologists and cancer patients.

According to this article, every year, dozens of products are released in global markets. In 2012, the US Food and Drug Administration (US FDA) approved 39 new medicines, up from 30 in 2011 and 21 in 2010. Generally, 30 to 40 per cent of new drugs are for cancer. The availability of new drugs varies by country. Kewal Handa, former managing director of Pfizer India, who now runs healthcare advisory Salus Lifecare, says: “The launch of these products depends on several factors, including market potential ­ the number of people who can afford them ­ and the time taken for approvals in the country.” He says it takes anywhere from four months to two years for a new product to enter India.

There are several reasons why multinational drug companies may find India underwhelming. A spokesperson for Pfizer in India, while emphasising that India is an important market, says: “A lack of clarity and inconsistency in Indian regulatory requirements will lead to a shift of clinicaltrial placements to other countries with a developed, science­based and consistent regulatory framework. In the absence of clinical trials in India, it will become difficult to register new drugs leading to Indian patients being denied access to new innovative medicines.”For a foreign company to launch a drug in India, prior approval in the US or Europe is not enough. The company must conduct “confirmatory trials” in India, to establish the safety and efficacy of the drug on Indians. The requirement can be waived in a few cases, such as a national emergency, but a Parliamentary standing committee has raised questions about some instances of waiver. In the light of this, many in the industry fear that the regulator, the Drug Controller General of India (DCGI), may take a risk­averse stance and insist on trials in every case. DCGI G.N. Singh defends trial requirements, saying that they are necessary to ensure patient safety.

So far, the only way out is for doctors to write to the companies and get medicines delivered on a case­by­case basis, either under the patient’s personal import licence or through the drug manufacturer’s patient assistance programme but this is not always easy and patients may end up losing time.

To read the entire article, click here.

Filed Under: Featured Tagged With: cancer, health

Reader Interactions

Leave a Reply Cancel reply

You must be logged in to post a comment.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Primary Sidebar

Articles

  • US declares monkeypox a public health emergency; The latest health stories from around the world
  • First Asian monkeypox death occurs in India
  • President Joe Biden tests positive for COVID-19 a second time; The latest health stories from around the world
  • Monkeypox officially declared a global emergency by WHO; The latest health stories from around the world
  • Four monkeypox cases now reported in India

Footer

Archives

Issues that matter

  • Environmental health
  • Inadequate safe drinking water
  • Poor sanitation
  • Infectious disease
  • Noncommunicable Diseases (NCDs)
  • Malnutrition
  • High infant mortality

Categories

Copyright © 2022 · News Pro On Genesis Framework · WordPress · Log in

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. However you may visit Cookie Settings to provide a controlled consent.
Cookie settingsACCEPTACCEPT ALL
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.